The modulation of T cell responses by Helicobacter pylori is thought to potentiate both H. pylori persistence and development of gastric pathologies including cancer. Release of outer membrane vesicles (OMV) by H. pylori provides a potential vehicle for modulation of the immune system. Although OMV are thought to have T cell suppressive activity, this has not yet been demonstrated. Their suppressive activity was investigated in this study using the responses of peripheral blood mononuclear cells (PBMC) to T cell stimuli as a readout. We demonstrate that addition of OMV to PBMC significantly inhibits subsequent T cell proliferation in a cyclo-oxygenase-2 (COX-2)-dependent manner. Addition of OMV did not significantly modulate PBMC apoptosis, but induced strong expression of COX-2 by the monocytes present and significantly increased levels of PGE 2 and IL-10. These effects were independent of vacuolating cytotoxin expression. Together, these findings demonstrate that OMV can suppress human T cell responses and that the predominant mechanism is not through a direct effect on the T cells but results from the induction of COX-2 expression in monocytes. This increased COX-2 activity may modulate not only H. pylori-directed immune responses but also wider immune responses.
INTRODUCTION
Helicobacter pylori is a gram-negative bacterium that colonises nearly half of the world's population and is associated with an increased incidence of gastric cancer (Uemura et al. 2001) . T cell responses play a critical role in controlling H. pylori infection, and modulation of these responses by the bacterium is thought to play a role in both H. pylori persistence and associated gastric pathologies (Lina et al. 2014; Larussa et al. 2015) .
Helicobacter pylori can suppress T cell responses either directly, by expression of molecules such as a vacuolating cytotoxin (Vac A) or indirectly, by stimulating other cell types to upregulate enzymatic generation of suppressive molecules (Larussa et al. 2015) . Helicobacter pylori is known to be a potent inducer of cyclo-oxygenase-2 (COX-2) (Meyer et al. 2003; Larussa et al. 2015) whose downstream product prostaglandin-E2 (PGE 2 ) cannot only skew and/or inhibit T cell responses but also promote angiogenesis and tumour growth (Kalinski 2012) . Although COX-2 induction is potentially a powerful mediator of H. pyloridriven suppression, human studies to date have not used assay systems that would detect its effect on T cell function.
Helicobacter pylori, in common with other gram-negative bacteria, shed outer membrane vesicles (OMV) that contain many of the bacterial outer membrane and periplasmic components (Mullaney et al. 2009; Parker and Keenan 2012) . Helicobacter pylori OMV are thought to make an important contribution to bacterial survival and/or pathogenesis (Chitcholtan, Hampton and Keenan 2008; Kaparakis-Liaskos and Ferrero 2015) . The observation that H. pylori and a number of its individual components can suppress T cell responses suggests that OMV release may provide a powerful vehicle by which H. pylori can deliver bacterial components to the immune system (Kaparakis-Liaskos and Ferrero 2015; Schwechheimer and Kuehn 2015) and suppress T cell responses (Kaparakis-Liaskos and Ferrero 2015; Lina et al. 2014; Larussa et al. 2015; Schwechheimer and Kuehn 2015) . However, recent studies provide strong evidence that it is the overall balance of synergies between all components present that determines the immunosuppressive capacity of complex bacterial structures (Beigier-Bompadre et al. 2011; Jones et al. 2016) . While the individual components in OMV are representative of the outer membrane of the parent bacterium, quantitative differences exist that reflect enrichment or exclusion of certain proteins and lipids (Kulp and Kuehn 2010) . Whether these differences make H. pylori OMV more or less immunosuppressive than the parent bacterium remains unknown.
In the current study, we investigate whether exposure of human peripheral blood mononuclear cells (PBMC) to OMV modulates T cell responses and, if so, whether it involves the induction of COX-2-mediated PGE 2 release.
MATERIALS AND METHODS
Detailed methods are provided in Supplementary Methods, Supporting Information.
Helicobacter pylori strains used were wild type (WT) 60190 and a mutant strain 60190:v1 (Vac-) with disrupted vacA (Cover et al. 1994) . Helicobacter pylori was grown in Brucella broth supplemented with fetal calf serum (FCS). OMV were harvested and washed using ultracentrifugation and individual aliquots stored at −80
• C , Parker et al. 2010 . Media without bacteria was also centrifuged in the same manner and used as a control for FCS-mediated effects. Blood was collected from laboratory staff donors (n = 9) following informed consent. PBMC were isolated and used either unlabelled or following labelling with carboxyfluorescein diacetate succinimidyl ester (CFSE).
For the proliferation assay, CFSE-labelled PBMC were incubated 24 h in the presence or absence of OMV then activated with CD3 mAb. Following 48 h activation, flow cytometric analysis of apoptosis (Annexin V) and cell death (propidium iodide (PI)) was performed. For proliferation analysis, matched wells were cultured a further 48 h and proliferation determined by flow cytometry.
To determine the effect of OMV on COX-2 expression and cytokine/PGE2 release, PBMC were cultured 24 h with OMV. Expression of COX-2 on monocytes was analysed by flow cytometry. IL-10 and PGE2 levels in the culture supernatants were determined by ELISA.
RESULTS AND DISCUSSION
The in vitro detection of a particular suppressive mechanism requires an appropriate methodology. The detection of COX-2-mediated suppression requires an assay system that both utilises APC-dependent T cell stimulation and includes a cell population such as monocytes that can upregulate COX-2 in response to stimuli (Chemnitz et al. 2006; Bryn et al. 2008) . The ability of OMV to suppress T cell responses was therefore analysed using an assay system that would allow detection of suppression due to both the direct, or indirect, effects of OMV on T cells.
The presence of OMV resulted in significant inhibition of T cell proliferation with similar levels observed using WT and Vac-OMV (Fig. 1A) . The potential effect of OMV on viability in the proliferation assays was then analysed (Fig. 1B; Fig. S1 , Supporting Information). Although addition of WT or Vac-OMV to the assay significantly suppressed proliferation, there was no significant change in the levels of Annexin V+ or PI+ PBMC. This is consistent with studies using H. pylori bacteria which have reported induction of apoptosis in pure T cells (Wang et al. 2001; Ganten et al. 2007; Beigier-Bompadre et al. 2011) but not PBMC (Gerhard et al. 2005; Torres et al. 2007) . A single study has reported that H. pylori OMV induce T cell apoptosis (Winter et al. 2014 ). In contrast, we found that OMV did not induce apoptosis in the T cell line Jurkat based on both annexin V staining and caspase 3 activity (Fig. S2 , Supporting Information). These contrasting findings probably reflect methodological differences between the studies. It is known that changes in H. pylori growth conditions can alter the characteristics of released OMV (Keenan and Allardyce 2000) , and as these studies used quite different growth media, this provides the most likely explanation of the difference in results. The use by Winter et al. (2014) of ammonium sulphate for OMV isolation may also potentially influence the level of apoptosis observed, given the high levels of this salt that remain in a redissolved precipitate (Matheus et al. 2009 ) .We found that low levels of ammonium sulphate can induce apoptosis in Jurkat (Fig. S2b, Supporting Information) .
The potential effect of OMV on COX-2 expression by PBMC was investigated. PBMC cultured alone did not express detectable COX-2. However, following culture with both WT and Vac-OMV, the mean fluorescent intensity of COX-2 staining on the monocytes present was increased 10-50-fold over that of negative controls demonstrating strong upregulation of COX-2 expression ( Fig. 1C; Fig. S3 , Supporting Information). As FCS components may be present in the OMV preparation and potentially mediate this effect, control preparations obtained using media without bacteria were analysed. These preparations did not induce COX-2 expression (Fig. S3, Supporting Information) . Analysis of the supernatants from cultures of PBMC with OMV demonstrated significant increases in PGE 2 release. Consistent with a previous report (Winter et al. 2014) , increased levels of IL-10 were also observed (Fig. 1D) . Other studies suggest that PGE 2 release may protect T cells from apoptosis (Goetzl, An and Zeng 1995; Weinlich et al. 2008) , and this may explain why PBMC and pure T cells differ in their sensitivity to H. pylori induced apoptosis.
We next investigated whether the suppression of T cell proliferation was dependent on COX-2 upregulation by monocytes. The COX-2 specific inhibitor NS-398 has been shown to specifically inhibit COX-2 activity in a range of cell types including human monocytes (Bryn et al. 2008; Chen et al. 2011) . Addition of NS-398 to cultures substantially prevented the suppression induced by both WT and Vac-OMV (Fig. 1E) . In contrast, NS-398 did not modulate proliferation of PBMC cultured alone. This, together with the observation that NS-398 did not suppress OMV-induced IL-10 release (data not shown) and did not induce apoptosis (Fig. 1, Supporting Information) , underlines the specificity of the inhibition. Additional support for the involvement of COX-2 enzymes was provided by the observation that the (E) CFSE-PBMC were cultured in the presence or absence of the indicated combinations of OMV, COX-2 inhibitor (NS-398) and control (DMSO) prior to activation with CD3 and analysis of proliferation at day 4. Data are from four separate experiments using CFSE-PBMC from three separate donors. Data from each experiment were expressed as a percentage relative to the levels of proliferation (42%-69%) observed in the respective cultures of PBMC alone (defined as 100%). Pooled data are shown as mean ± SEM. Data in (A) and (E) were analysed by paired t-test and data in (B-D) analysed by repeated measures ANOVA. * P < 0.05; * * P < 0.01; * * * P < 0.001.
well-defined COX-1/COX-2 inhibitor Indomethacin had the same effect as NS-398 (Fig. 4, Supporting Information) . The importance of monocytes in mediating suppression was emphasised by the finding that OMV did not suppress the proliferation of pure T cells stimulated 72 h with CD3/CD28 (data not shown). OMV-induced suppression was observed using PBMC from all nine donors analysed. The H. pylori status of these donors is unknown but there are likely to be <20% seropositives based on local population data (Collett et al. 1999 ). Memory T responses to H. pylori may impact on the level of suppression induced in vivo. However, as this study's assay system utilises polyclonal T cell activation, the observed variation in suppression between donors is likely to reflect individual differences in monocyte numbers and receptor expression, rather than memory T responses.
Although some of the individual components of OMV have the capacity to directly suppress T cell responses (Boncristiano et al. 2003; Sundrud et al. 2004; Schmees et al. 2007) , we found no evidence that such mechanisms make a major contribution to the immunosuppressive activity of OMV. This may reflect the use in our study of OMV preparations rather than purified single components, as studies using both H. pylori-and Neisseria meningitides-generated OMV provide strong evidence that it is the overall balance of vesicle components that determines suppressive capacity (Beigier-Bompadre et al. 2011; Jones et al. 2016) .Thus, the use in the current study of whole OMV preparations and a mix of responders (PBMC) is likely to be a more physiologically relevant model than an individual component added to pure T cells.
In summary, this study provides the first demonstration that H. pylori OMV can suppress T cell responses through induction of COX-2 expression in monocytes. Given the multiple effects that COX-2 expression and associated PGE 2 release has, this finding has implications for the function of the immune system at sites of exposure to OMV. These data add to that from other studies suggesting that OMV release provides a vehicle by which H. pylori may shape immune responses.
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